e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
Evaluation of immunogenicity and effectiveness of low dose dTap-IPV vaccine used as booster in 4-8 year old children
![PDF) Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children ... PDF) Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children ...](https://i1.rgstatic.net/publication/221825930_Booster_vaccination_of_pre-school_children_with_reduced-antigen-content_diphtheria-tetanus-acellular_pertussis-inactivated_poliovirus_vaccine_co-administered_with_measles-mumps-rubella-varicella_vacci/links/021601cb0cf230b64ddf60de/largepreview.png)
PDF) Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children ...
Infanrix hexa, INN-Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
![A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ... A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X18303669-gr1.jpg)
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...
![The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine](https://www.thelancet.com/cms/asset/2af9ebf0-07eb-43a8-8696-b13d8cf0641d/gr1.jpg)